Jesper Bøje Andersen

Jesper Bøje Andersen

Professor

ORCID: 0000-0003-1760-5244
51 - 57 out of 57Page size: 10
Sort by: Start date
  1. 2009

  2. EASL: Modulation of Demethylation and Antitumor Potential of Zebularine in Liver Cancer

    Andersen, Jesper Bøje (Speaker)

    2009

    Activity: Talk or presentation types › Lecture and oral contribution

  3. Hepatology (Journal)

    Andersen, Jesper Bøje (Review editor)

    2009

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

  4. ILCA: Genomic and Epigenetic-Based Prediction of Response to Zebularine Therapy in Human Liver Cancer

    Andersen, Jesper Bøje (Speaker)

    2009

    Activity: Talk or presentation types › Lecture and oral contribution

  5. 2008

  6. Breast Cancer Research; Biochemical Pharmacology (Journal)

    Andersen, Jesper Bøje (Review editor)

    2008

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

  7. 2007

  8. ISICR: The Ribosomal Machinery is a Primary Target of RNase-L Regulation and may mediate its Roles in Senescence and Longevity

    Andersen, Jesper Bøje (Speaker)

    2007

    Activity: Talk or presentation types › Lecture and oral contribution

  9. Journal of National Cancer Institute (Journal)

    Andersen, Jesper Bøje (Review editor)

    2007

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

  10. 2006

  11. Nucleic Acids Research (Journal)

    Andersen, Jesper Bøje (Review editor)

    2006

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

Previous 12 3 4 5 6 Next

ID: 93714085